Integrin-Linked Kinase Is a Novel Therapeutic Target in Ovarian Cancer

Integrin-Linked Kinase Is a Novel Therapeutic Target in Ovarian Cancer

Objective: The objective of this study is to identify and validate novel therapeutic target(s) in ovarian cancer. Background: Development of targeted therapeutics in ovarian cancer has been limited by molecular heterogeneity. Although gene expression datasets are available, most of them lack appropr...

Full description

Bibliographic Details
Main Authors: Michael A. Ulm, Tiffany M. Redfern, Ben R. Wilson, Suriyan Ponnusamy, Sarah Asemota, Patrick W. Blackburn, Yinan Wang, Adam C. ElNaggar, Ramesh Narayanan
Format: Article
Language:English
Published: MDPI AG 2020-11-01
Series:Journal of Personalized Medicine
Subjects:
integrin-linked kinase (ILK)
ovarian cancer
sgRNA
gene expression
microarray
xenograft
Online Access:https://www.mdpi.com/2075-4426/10/4/246

Similar Items

Similar Items